BI Engage


What's New
Bug fix...
Size:
28.6 MB
Category:
Business
OS:
iOS
Developer:
CrowdCompass, Inc.
Price:
Free
Compatible:
iPhone iPad
Requirements:
Requires iOS 7.0 or la
Version:
1.2

Description - BI Engage

CrowdCompass, Inc. , the publisher behind many iOS app (2011 PPS Annual Conference ,NASSP Breaking Ranks K-12 Conference ,JFNA Tribefest 2012 ,EyeWorld2011 Symposia-HD ,ANI 2011 ,ANESTHESIOLOGY 2011), brings BI Engage with a number of new features along with the usual bug fixes. BI Engage app has been update to version 1.2 with several major changes and improvements. App release that improves performance, provides several new options.

.


If you are iPhone and iPad owner,you now can download BI Engage for free from Apple Store. The application is supporting different languages: English, Dutch, French, German, Hebrew, Italian, Polish, Portuguese, Romanian, Russian, Simplified Chinese, Spanish, Traditional Chinese, Turkish. It weighs in at only 28.6 MB to download. It is highly advisable to have the latest app version installed so that you don`t miss out on the fresh new features and improvements. The current app version 1.2 has been released on 2014-12-15. The Apple Store includes a very useful feature that will check if your device and iOS version are both compatible with the app. Most iPhone and iPad are compatible. Here is the app`s compatibility information: Requires iOS 7.0 or later. Compatible with iPhone, iPad, and iPod touch. This app is optimized for iPhone 5.
More Info: Find more info about BI Engage in CrowdCompass, Inc.`s Official Website : http://www.crowdcompass.com


Presenting the mobile application for internal Boehringer Ingelheim events in Australia & New Zealand. This app is password protected and is only for the use of Boehringer Ingelheim employees in Australia & New Zealand.
BI Engage Business Boehringer IngelheimBI Engage Business Boehringer IngelheimBI Engage Business Boehringer IngelheimBI Engage Business Boehringer Ingelheim


More in Business -BI Engage

Ingelheim Boehringer Boehringer Ingelheim